- Astepro provides up to 24-hour relief from nasal congestion, runny nose, sneezing and itchy nose.
- Each metered spray delivers 205.5 mcg azelastine HCl; this listing (Mfr# 00280006501) is a 60-metered-spray presentation.
- For ages 6 years and older; steroid-free antihistamine nasal spray.
- SKU:
- 1231793
- QTY Per Sell:
- 1
- UPC:
- 041100589927
- Active Ingredients:
- azelastine hydrochloride 205.5 mcg per spray
- Strength:
- 0.15% azelastine HCl (205.5 mcg/spray)
- Dosage Instructions:
- Adults/12+: 1 spray/nostril once or twice daily
- Children 6–11: 1 spray/nostril twice daily
- Prime before first use; repriming if unused ≥3 days
- Bottle Size / Sprays:
- 60 metered sprays (this listing); other bottles (30 mL) provide 200 sprays
- OTC / Rx Status:
- OTC (FDA approved OTC June 17, 2021)
- NDC:
- NDC 0037-0243-30 (30 mL / 200 sprays label). Mfr item 00280006501 for 60-spray pack.
- Inactive Ingredients:
- Sorbitol
- Sucralose
- Hypromellose; benzalkonium chloride
- Storage:
- Store upright 20°–25°C (68°–77°F); protect from freezing
- Priming & Use:
- Initial prime: 6 sprays
- Reprime: 2 sprays after ≥3 days unused
- Warnings (brief):
- Avoid spraying in eyes
- May cause somnolence; avoid driving if affected
- Avoid alcohol/CNS depressants
- Manufacturer:
- Bayer / Meda Pharmaceuticals (manufactured for Meda; marketed as Astepro)
- Manufacturer Link:
- https://www.asteproallergy.com/
- Regulatory / Source Notes:
- FDA approval for OTC switch: June 17, 2021
- Package insert/DailyMed prescribing info used
- SKU:
- 1231793
- QTY Per Sell:
- 1
- UPC:
- 041100589927
- ic__sync_id:
- 2
- ic__id:
- 4788
- Active Ingredients:
- azelastine hydrochloride 205.5 mcg per spray
- Strength:
- 0.15% azelastine HCl (205.5 mcg/spray)
- Dosage Instructions:
- Adults/12+: 1 spray/nostril once or twice daily
- Children 6–11: 1 spray/nostril twice daily
- Prime before first use; repriming if unused ≥3 days
- Bottle Size / Sprays:
- 60 metered sprays (this listing); other bottles (30 mL) provide 200 sprays
- OTC / Rx Status:
- OTC (FDA approved OTC June 17, 2021)
- NDC:
- NDC 0037-0243-30 (30 mL / 200 sprays label). Mfr item 00280006501 for 60-spray pack.
- Inactive Ingredients:
- Sorbitol
- Sucralose
- Hypromellose; benzalkonium chloride
- Storage:
- Store upright 20°–25°C (68°–77°F); protect from freezing
- Priming & Use:
- Initial prime: 6 sprays
- Reprime: 2 sprays after ≥3 days unused
- Warnings (brief):
- Avoid spraying in eyes
- May cause somnolence; avoid driving if affected
- Avoid alcohol/CNS depressants
- Manufacturer:
- Bayer / Meda Pharmaceuticals (manufactured for Meda; marketed as Astepro)
- Manufacturer Link:
- https://www.asteproallergy.com/
- Regulatory / Source Notes:
- FDA approval for OTC switch: June 17, 2021
- Package insert/DailyMed prescribing info used
